EDGAR Filing Documents for 0001052918-21-000217

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001052918-21-000217

Filing Date

2021-06-17

Accepted

2021-06-17 17:23:13

Documents

Period of Report

2020-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	AVRICORE HEALTH INC.	avricore6kjune2020.htm	6-K	10703
2	EXHIBIT 99.1	fs_ex99z1.htm	EX-99.1	239525
3	EXHIBIT 99.2	mda_ex99z2.htm	EX-99.2	99356
4	EDHIBIT 99.3	ceocert_ex99z3.htm	EX-99.3	6171
5	EXHIBIT 99.4	cfocert_ex99z4.htm	EX-99.4	6149
6	EXHIBIT 99.5	nr_ex99z5.htm	EX-99.5	6308
7	IMAGE	fsex99z1_1.jpg	GRAPHIC	6822
8	IMAGE	mdaex99z2_1.jpg	GRAPHIC	6822
9	IMAGE	nrex99z5_1.jpg	GRAPHIC	6822
	Complete submission text file	0001052918-21-000217.txt		398143

Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2

Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038

Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)